Physician profile
Robert E Neville
NPI 1023052974
$7,025.16
in general payments reported to CMS, 2019-2025
15 companies · $1,057 in 2025
The $1,057 reported for 2025 was more than what 87% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,246 · 2020: $346 · 2021: $442 · 2022: $549 · 2023: $1,223 · 2024: $1,163 · 2025: $1,057.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,112 · Food and Beverage: $1,319 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,112.18 |
| Food and Beverage | $1,318.94 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $3,151.47 | 2022-2025 | |
| Pylant Medical | $1,115.00 | 2019 | |
| Medinc of Texas | $951.00 | 2019 | |
| Stryker Corporation | $760.64 | 2019-2024 | Augment Injectable |
| Organogenesis INC. | $357.01 | 2020-2024 | Nushield |
| Alafair Biosciences, INC. | $250.00 | 2022 | |
| Horizon Therapeutics Plc | $124.98 | 2021 | |
| Bone Support INC. | $91.63 | 2019 | |
| Abbott Laboratories | $80.30 | 2023 | Octrode |
| Melinta Therapeutics, LLC | $34.98 | 2021 | |
| Ossio INC | $31.89 | 2021 | |
| Arthrosurface Incorporated | $24.67 | 2019 | |
| Paratek Pharmaceuticals, INC. | $23.88 | 2020 | |
| Integra Lifesciences Corporation | $14.27 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Merck Sharp & Dohme LLC | $13.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Neville listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.